Literature DB >> 20837078

Lipopolysaccharide from Burkholderia thailandensis E264 provides protection in a murine model of melioidosis.

Sarah A Ngugi1, Valeria V Ventura, Omar Qazi, Sarah V Harding, G Barrie Kitto, D Mark Estes, Anne Dell, Richard W Titball, Timothy P Atkins, Katherine A Brown, Paul G Hitchen, Joann L Prior.   

Abstract

Burkholderia thailandensis is a less virulent close relative of Burkholderia pseudomallei, a CDC category B biothreat agent. We have previously shown that lipopolysaccharide (LPS) extracted from B. pseudomallei can provide protection against a lethal challenge of B. pseudomallei in a mouse model of melioidosis. Sugar analysis on LPS from B. thailandensis strain E264 confirmed that this polysaccharide has a similar structure to LPS from B. pseudomallei. Mice were immunised with LPS from B. thailandensis or B. pseudomallei and challenged with a lethal dose of B. pseudomallei strain K96243. Similar protection levels were observed when either LPS was used as the immunogen. This data suggests that B. thailandensis LPS has the potential to be used as part of a subunit based vaccine against pathogenic B. pseudomallei. Crown
Copyright © 2010. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20837078     DOI: 10.1016/j.vaccine.2010.08.058

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  27 in total

1.  Burkholderia pseudomallei capsular polysaccharide conjugates provide protection against acute melioidosis.

Authors:  Andrew E Scott; Mary N Burtnick; Margaret G M Stokes; Adam O Whelan; E Diane Williamson; Timothy P Atkins; Joann L Prior; Paul J Brett
Journal:  Infect Immun       Date:  2014-05-27       Impact factor: 3.441

2.  A naturally derived outer-membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection.

Authors:  Wildaliz Nieves; Saja Asakrah; Omar Qazi; Katherine A Brown; Jonathan Kurtz; David P Aucoin; James B McLachlan; Chad J Roy; Lisa A Morici
Journal:  Vaccine       Date:  2011-08-24       Impact factor: 3.641

3.  Designing inorganic nanomaterials for vaccines and immunotherapies.

Authors:  Krystina L Hess; Igor L Medintz; Christopher M Jewell
Journal:  Nano Today       Date:  2019-05-29       Impact factor: 20.722

4.  Use of Reverse Vaccinology in the Design and Construction of Nanoglycoconjugate Vaccines against Burkholderia pseudomallei.

Authors:  Laura A Muruato; Daniel Tapia; Christopher L Hatcher; Mridul Kalita; Paul J Brett; Anthony E Gregory; James E Samuel; Richard W Titball; Alfredo G Torres
Journal:  Clin Vaccine Immunol       Date:  2017-11-06

5.  Protection against experimental melioidosis following immunization with live Burkholderia thailandensis expressing a manno-heptose capsule.

Authors:  Andrew E Scott; Thomas R Laws; Riccardo V D'Elia; Margaret G M Stokes; Tannistha Nandi; E Diane Williamson; Patrick Tan; Joann L Prior; Timothy P Atkins
Journal:  Clin Vaccine Immunol       Date:  2013-05-15

6.  Detailed structural analysis of the O-polysaccharide expressed by Burkholderia thailandensis E264.

Authors:  Christian Heiss; Mary N Burtnick; Ian Black; Parastoo Azadi; Paul J Brett
Journal:  Carbohydr Res       Date:  2012-10-11       Impact factor: 2.104

7.  Multicomponent Gold-Linked Glycoconjugate Vaccine Elicits Antigen-Specific Humoral and Mixed TH1-TH17 Immunity, Correlated with Increased Protection against Burkholderia pseudomallei.

Authors:  Daniel Tapia; Javier I Sanchez-Villamil; Heather L Stevenson; Alfredo G Torres
Journal:  mBio       Date:  2021-06-29       Impact factor: 7.867

Review 8.  Burkholderia vaccines: are we moving forward?

Authors:  Leang-Chung Choh; Guang-Han Ong; Kumutha M Vellasamy; Kaveena Kalaiselvam; Wen-Tyng Kang; Anis R Al-Maleki; Vanitha Mariappan; Jamuna Vadivelu
Journal:  Front Cell Infect Microbiol       Date:  2013-02-05       Impact factor: 5.293

9.  Vaccines for the Prevention of Melioidosis and Glanders.

Authors:  Monica M Johnson; Kristy M Ainslie
Journal:  Curr Trop Med Rep       Date:  2017-07-14

10.  A gold nanoparticle-linked glycoconjugate vaccine against Burkholderia mallei.

Authors:  Anthony E Gregory; Barbara M Judy; Omar Qazi; Carla A Blumentritt; Katherine A Brown; Andrew M Shaw; Alfredo G Torres; Richard W Titball
Journal:  Nanomedicine       Date:  2014-09-03       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.